COGNITIVE & NOOTROPIC
Cognitive & Nootropic research peptides: mood, stress and anxiolytic science
An independent reading desk for the published literature on Selank and DSIP — two neuroactive research peptides studied for anxiety, stress resilience, and sleep. What each was actually studied for, in which species, and how strong the evidence is.
Selank
A tuftsin-analogue heptapeptide studied for anxiolytic effects via GABAergic modulation — calming without sedation is the most consistent report, from both animal models and limited Russian clinical work.
Read the research →
DSIP
An endogenous nonapeptide named for early sleep-promoting findings that have proved surprisingly hard to replicate — the science is genuinely unresolved, and a large share of users report no effect at all.
Read the research →The short version
Peptivio Peptides is a reading desk, not a store. It collects what the published research literature actually says about two neuroactive peptides that keep coming up in conversations about mood, stress and sleep: Selank and DSIP. A peptide is just a short chain of amino acids — the same building blocks that make up proteins, only far smaller. Each of these two has been studied because it seems to nudge parts of the nervous system involved in how we handle stress, anxiety, and the transition into sleep.
This guide does one job: it tells you, in plain language and with citations, what each peptide was tested on, in which species, and how far that evidence reaches. Much of it stops well short of humans. Neither is an approved medicine in the United States. We do not sell anything, we do not give medical advice, and we never list a human dose. The theme here is mood, stress and anxiolytic-peptide research — a quiet, accurate map of what is known so you can judge the science yourself.
What are Cognitive & Nootropic research peptides?
A nootropic (from Greek nous, mind, and tropos, turning) is any compound studied for effects on cognition, mood, stress response, or sleep. Research peptides in this category are short amino-acid chains — typically fewer than fifteen residues — that have been synthesized and studied in the laboratory but have not been approved by a regulator as a medicine. Sellers describe them strictly as laboratory research materials.
The neuroactive peptides on this desk are not stimulants. They work closer to the brain's own regulatory chemistry — the GABAergic inhibitory system, the stress-hormone axis, endogenous sleep signals — and the research questions center on whether they can tilt that chemistry in useful directions without the side-effect profiles of classical psychiatric drugs. When this desk reports a number or a finding it attributes it to the study it came from, in the species it was studied in, and never as a recommendation for human use.
How Selank and DSIP fit into mood and stress research
The two peptides on this desk approach the mood-and-stress space from very different angles, which is exactly why they sit together.
- Selank is the lead. It is a synthetic heptapeptide derived from the endogenous immunomodulatory tetrapeptide tuftsin, extended to improve metabolic stability. In animal models and limited Russian clinical studies, it produced anxiolytic effects attributed to positive allosteric modulation of GABA receptors and inhibition of enkephalin-degrading enzymes — a mechanism with meaningful clinical data behind it but a narrow, single-region evidence base [1][6][7].
- DSIP, Delta Sleep-Inducing Peptide, is a nine-amino-acid endogenous neuropeptide first isolated from the cerebral blood of sleeping rabbits. It was named for its apparent ability to promote slow-wave sleep, but more than four decades of follow-up research have produced inconsistent results — a 2006 Journal of Neurochemistry review described the sleep evidence as "extremely poorly documented and still weak" and noted no receptor, gene, or precursor has been identified [9].
Together they sketch two sides of the mind-quieting question: a compound with a reasonably characterized mechanism (Selank) and one whose mechanism remains genuinely unresolved (DSIP). Compare these peptides side by side.
A note on how this desk reads the literature
Peptivio Peptides is a cross-referenced literature digest. Each peptide page summarizes the peer-reviewed studies, cites them by number, and links to a single shared references list. Where the evidence is thin, single-lab, or preclinical-only, we say so — that caution is part of the record, not a footnote. We present real-world community reports where the corpus carries them, always explicitly labeled "anecdotal, not clinical evidence" — because what users report and what studies show are different kinds of information, and conflating them is a disservice to the reader. We describe findings and cautions; we do not recommend, prescribe, or sell.